Clinical Trial Update: Investigating Safety and Pharmacokinetics of NNC 0128-0000-2011 Compared to NNC 0128-0000-2021 in Healthy Male Subjects [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating safety and pharmacokinetics of two investigational products, NNC 0128-0000-2011 and NNC 0128-0000-2021, in healthy male subjects; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• NNC 0128-0000-2011
• NNC 0128-0000-2021

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Congenital Bleeding Disorder, Haemophilia A | Phase 1 | Status: COMPLETED